Itziar Otano
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Epidemiology 13
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 4
- Oncology 12
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 6
- Co-authors
- Ignacio Melero (7 shared papers)Pedro Berraondo (12 shared papers)Gloria González‐Aseguinolaza (13 shared papers)Maite Álvarez (6 shared papers)Jesús Prìeto (12 shared papers)Luna Minute (4 shared papers)María C. Ochoa (3 shared papers)Álvaro Teijeira (4 shared papers)
- Journals
- Journal of Virology (4 papers)Molecular Therapy (3 papers)Cancer Research (3 papers)Journal for ImmunoTherapy of Cancer (2 papers)Scientific Reports (1 paper)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Itziar Otano
27 papers receiving 1.2k citations
Itziar Otano's Hit Papers
Peers
Comparison fields: 5 of 74
- Immunology 620
- Oncology 681
- Hepatology 131
- Genetics 219
- Epidemiology 241
Countries citing papers authored by Itziar Otano
This map shows the geographic impact of Itziar Otano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itziar Otano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itziar Otano more than expected).
Fields of papers citing papers by Itziar Otano
This network shows the impact of papers produced by Itziar Otano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itziar Otano. The network helps show where Itziar Otano may publish in the future.
Co-authors
The 25 scholars most cited alongside Itziar Otano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy Hit paper breakdown → | 2019 | 323 |
| 2 | 2016 | 184 | |
| 3 | 2017 | 107 | |
| 4 | 2009 | 87 | |
| 5 | At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC Hit paper breakdown → | 2023 | 84 |
| 6 | 2018 | 78 | |
| 7 | 2020 | 71 | |
| 8 | 2011 | 50 | |
| 9 | 2009 | 41 | |
| 10 | 2020 | 31 | |
| 11 | 2008 | 31 | |
| 12 | 2011 | 24 | |
| 13 | 2015 | 22 | |
| 14 | 2018 | 21 | |
| 15 | 2012 | 18 | |
| 16 | 2017 | 17 | |
| 17 | 2016 | 16 | |
| 18 | 2021 | 13 | |
| 19 | 2008 | 12 | |
| 20 | 2011 | 10 |
About Itziar Otano
Itziar Otano is a scholar working on Epidemiology, Oncology, Immunology, Genetics and Infectious Diseases, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), Immunotherapy and Immune Responses (8 papers), Virus-based gene therapy research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Animal Virus Infections Studies (3 papers). The work is most often cited by research in Immunology (620 citations), Oncology (681 citations), Hepatology (131 citations), Genetics (219 citations) and Epidemiology (241 citations). Itziar Otano has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Ignacio Melero, Pedro Berraondo, Gloria González‐Aseguinolaza, Maite Álvarez, Jesús Prìeto, Luna Minute, María C. Ochoa, Álvaro Teijeira, José Luis Perez‐Gracia and María E. Rodríguez-Ruiz. Their work appears in journals such as Journal of Virology, Molecular Therapy, Cancer Research, Journal for ImmunoTherapy of Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.